AHPA has written to the CEO of the National Disability Insurance Agency (NDIA), Rob de Luca, asking for an immediate halt to the implementation of tiered therapy pricing.
AHPA and our member associations are extremely concerned about the NDIA’s decision to implement tiered therapeutic pricing, as outlined in Recommendation 17 of the recently released McKinsey and Company Independent Pricing Review.
AHPA believes that the recommendations around tiered pricing are based on an incomplete understanding of the support needs of people with disability and the pricing of various accident compensation and insurance schemes around Australia.
We are also concerned about the lack of consultation with allied health peak bodies and the decision to implement the recommendation nationally without first testing its impact on the marketplace.
AHPA has also engaged with the NDIA Board and the Assistant Minister for Disability Services requesting an immediate halt to the implementation process.
Update: AHPA is pleased to report that the NDIA did not introduce a tiered pricing structure for the NDIS. In March 2019 it was announced that NDIS therapy prices would increase (from 1 July 2019) and would continue to have a single price level for most services.